APOTHEEK WILDERT
ActiveAPOTHEEK WILDERT has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €427k and a net result of €105k. Equity is growing by ~7.3% per year across the filed fiscal years. Its solvency ranks better than 52% of 10242 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).
Checked score
Score 2025
94
/ 100
Excellent▲ +8 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+5
Solvency82▲+2
Growth78▲+26
Stability100
Bankruptcy probability, 12 months
0.5%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 2.33 against 2.39 in 2024), but 61.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
38.7%
Return on assets
9.5%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-08-2026, 7 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
7 d late
2024
5 d late
2023
15 d late
2022
9 d early
2021
19 d late
2020
18 d late
2019
9 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€427k=
2024 · €427k
2018: €204k
2019: €261k
2020: €347k
2021: €356k
2022: €372k
2023: €398k
2024: €427k
2018 → 2025
Total assets
€1.10M▼ 4.2%
2024 · €1.15M
2018: €579k
2019: €865k
2020: €1.24M
2021: €1.22M
2022: €1.22M
2023: €1.27M
2024: €1.15M
2018 → 2025
Net result
€105k▲ 29.4%
2024 · €81k
2018: €82k
2019: €57k
2020: €104k
2021: €68k
2022: €89k
2023: €98k
2024: €81k
2018 → 2025
Working capital
€390k▲ 1.4%
2024 · €385k
2018: €164k
2019: €200k
2020: €291k
2021: €310k
2022: €328k
2023: €354k
2024: €385k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€356k-€372k▲ 4.5%€398k▲ 7.0%€427k▲ 7.4%€427k=
Operating result€88k-€110k▲ 25.6%€123k▲ 11.2%€107k▼ 13.2%€117k▲ 9.8%
Net result€68k-€89k▲ 30.6%€98k▲ 10.3%€81k▼ 17.1%€105k▲ 29.4%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 10% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.10M
Fixed assets
€420k▼ 14.4%
Current assets
€684k▲ 3.3%
Equity and liabilities €1.10M
Equity
€427k=
Debt
€677k▼ 6.8%
The debt ratio falls from 63.0% to 61.3%: debt is paid down.
Key figures and ratios
EBITDA
€188k▲
2024 · €179k
Cash flow
€176k▲
2024 · €154k
Solvency
38.7%▲
2024 · 37.0%
Current ratio
2.33▼
2024 · 2.39
Quick ratio
1.77▼
2024 · 1.81
Debt / equity
1.58▼
2024 · 1.70
ROE
24.6%▲
2024 · 19.0%
ROA
9.5%▲
2024 · 7.1%
Interest coverage
14.37▲
2024 · 12.51
Debt
€677k▼
2024 · €726k
Debt ≤ 1 year
€294k▲
2024 · €278k
Debt > 1 year
€375k▼
2024 · €441k
Income taxes
€2k▼
2024 · €11k
Staff costs
€87k▼
2024 · €109k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.15M€1.10M▼
Fixed assets21/28€490k€420k▼
Tangible fixed assets22/27€490k€419k▼
Land and buildings22€239k€222k▼
Plant, machinery and equipment23€251k€197k▼
Financial fixed assets28€425€425=
Current assets29/58€662k€684k▲
Stocks and contracts in progress3€158k€162k▲
Stocks30/36€158k€162k▲
Amounts receivable within one year40/41€121k€170k▲
Trade receivables40€119k€161k▲
Other amounts receivable41€2k€9k▲
Current investments50/53€150k€0▼
Cash at bank and in hand54/58€223k€335k▲
Deferred charges and accrued income490/1€10k€17k▲
Equity and liabilities
Total equity and liabilities10/49€1.15M€1.10M▼
Equity10/15€427k€427k=
Contributions10/11€19k€19k=
Reserves13€135k€135k=
Tax-exempt reserves132€25k€25k=
Distributable reserves133€110k€110k=
Profit (loss) carried forward14€273k€273k▲
Amounts payable17/49€726k€677k▼
Amounts payable after more than one year17€441k€375k▼
Financial debts170/4€441k€375k▼
Amounts payable within one year42/48€278k€294k▲
Current portion of amounts payable after more than one year42€64k€65k▲
Trade debts44€55k€106k▲
Suppliers440/4€55k€106k▲
Taxes, remuneration and social security45€12k€10k▼
Taxes450/3€0€837▲
Remuneration and social security454/9€12k€9k▼
Other amounts payable47/48€146k€112k▼
Accrued charges and deferred income492/3€7k€7k▼
Income statement
Code20242025
Remuneration, social security and pensions62€109k€87k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€72k€71k▼
Other operating charges640/8€260€292▲
Gross operating margin9900€288k€275k▼
Operating profit (loss)9901€107k€117k▲
Financial income75/76B-€3k
Recurring financial income75-€3k
Financial charges65/66B€14k€13k▼
Recurring financial charges65€14k€13k▼
Profit (loss) for the period before taxes9903€92k€107k▲
Income taxes67/77€11k€2k▼
Profit (loss) for the period9904€81k€105k▲
Profit (loss) for the period to be appropriated9905€81k€105k▲
Appropriation of the result
Profit (loss) to be appropriated9906€325k€378k▲
Profit (loss) brought forward from the previous period14P€244k€273k▲
Profit to be distributed694/7€52k€105k▲
Directors or managers695€52k€105k▲
Social balance
Average headcount (FTE)90872.31.9▼
The notes to these accounts (18 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
07-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 7 days late
2025
31-12
Financial
Highest result since 2018net €105k ▲29.4%
Net result €105k, the highest in the series.
05-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 5 days late
2024
15-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 15 days late
2023
22-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
19-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 19 days late
2021
18-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 18 days late
2020
22-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Weakest financial yearnet €57k ▼30%
Net result drops to €57k, the lowest in the series; recovery starts the following year.
22-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
03-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 3 days late
2017
04-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 4 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Essen · 1 establishment unit since 2003
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Sint-Jansstraat 28B2910 EssenGround area
1,693 m²
Building footprint
636 m²
Volume, LiDAR
3,314 m³
2 parcels, Flanders · tallest building 15.2 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Sint-Jansstraat 28, 2910 Essen
since 20032.126.658.187
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11642C0544/00H003 | Flanders | 1,179 m² | 1 · 636 m² | 15.2 m · 1 fl. |
| 11642C0581/00K003 | Flanders | 513 m² | - | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 5 entries · 2,637 EUR awarded · 2,541 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 87 EUR | 87 EUR |
| 2024 | 2 | 2,045 EUR | 2,045 EUR |
| 2023 | 1 | 297 EUR | 201 EUR |
| 2022 | 1 | 208 EUR | 208 EUR |
Schemes
Hinderpremie bij openbare werken
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Food safety, FASFC
1 siteEssen2.126.658.187
Similar companies · same sector, comparable size
PHARMACIE MANDRAGORE
BE 0452.802.037
Quaregnon · Eq €427k
PHARMACIE BERTRAND
BE 0411.901.689
Sombreffe · Eq €428k
APOTHEEK LOPPEM
BE 0425.373.902
Zedelgem · Eq €427k
DOMICAPHARMA
BE 0798.126.193
Sint-Laureins · Eq €426k
APOTHEEK CZIJZ-BATSELIER
BE 0874.514.188
Gent · Eq €426k
Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 3,409 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-03-2003
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 23 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:info@apotheekwildert.be